Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,264 | 14,802 | 1,073 | 2,216 | 12,963 |
| Marketable Securities | 30,183 | 30,212 | 20,212 | 21,495 | 14,688 |
| TOTAL | $45,764 | $45,855 | $22,168 | $25,320 | $28,640 |
| Non-Current Assets | |||||
| PPE Net | 71 | 65 | 53 | 41 | 46 |
| Other Non-Current Assets | 9 | 9 | 9 | 9 | 9 |
| TOTAL | $80 | $74 | $62 | $50 | $55 |
| Total Assets | $45,845 | $45,929 | $22,230 | $25,370 | $28,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 525 | 1,238 | 932 | 851 | 1,473 |
| Accrued Expenses | 5,414 | 1,126 | 1,505 | 1,289 | 1,538 |
| TOTAL | $5,939 | $2,364 | $2,437 | $2,140 | $3,012 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,283 | 2,377 | 2,155 | 1,839 | 3,564 |
| TOTAL | $3,283 | $2,377 | $2,155 | $1,839 | $3,564 |
| Total Liabilities | $9,222 | $4,741 | $4,591 | $3,978 | $6,576 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,119 | 67,169 | 67,169 | 54,146 | 54,133 |
| Common Shares | 67 | 67 | 54 | 54 | 54 |
| Retained earnings | -66,353 | -61,343 | -58,145 | -54,334 | -52,979 |
| TOTAL | $36,623 | $41,188 | $17,638 | $21,391 | $22,119 |
| Total Liabilities And Equity | $45,845 | $45,929 | $22,230 | $25,370 | $28,695 |